Global Total Parenteral Nutrition (TPN) Bags Market Anticipated to Reach USD 1,102.41 Million by 2031

According to a recent market study published by Growth Market Reports, titled, “Global Total Parenteral Nutrition (TPN) Bags Market is segmented into by product type, by age group, by end user, by application and by region: Size, Share, Trends and Opportunity Analysis, 2016-2031”, the market was valued at US$ 561.11 million in 2022 and is expected to grow at a growth rate of 7.9% by the year 2031.

Total Parenteral Nutrition (TPN) bags are pre-mixed containers that provide essential nutrients, vitamins, and minerals to patients who require parenteral nutrition. These bags are used to deliver a complete diet to patients who cannot absorb nutrients through their digestive system, usually due to gastrointestinal disorders, surgical removal of the stomach or small intestine, malabsorption syndromes, severe trauma or burns, or chronic diseases.

A typical TPN bag contains a combination of amino acids, dextrose (glucose), fatty acids, electrolytes, vitamins, and lipid emulsions. The exact composition of the bag may vary depending on the patient's specific needs and medical condition. For example, patients with certain deficiencies may require additional vitamins or minerals. The bag is prepared in a sterile environment and must be administered through a central venous catheter or peripherally inserted central catheter (PICC line) under the supervision of a healthcare professional.

Get Sample Report @ https://growthmarketreports.com/request-sample/6638

Based on type, the total parenteral nutrition (TPN) bags market is segmented into single chamber and multi chamber. The Single Chamber segment holds 68.6% market value share in 2022, owing to the rising due to the growing demand for advanced drug delivery systems, driving the need for innovative single chamber parenteral bags that deliver complex therapies effectively.

On the basis of age group, the total parenteral nutrition (TPN) bags market is segmented into 200 ml, 250 ml, 300 ml, 500 ml, 1000 ml, 2000 ml, 2500 ml, 3000 ml, 3500 ml, and 4000 ml. The 1000 ml segment holds 21.6 % market value share in 2022, owing to the rising due to the driving the need for TPN bags in various sizes to accommodate different treatment requirements increasing significance of TPN bags in the parenteral nutrition, indicating growing trend of market.

Based on age group, the total parenteral nutrition (TPN) bags market is segmented into pediatric and adult. The Adult segment holds 77.6% market value share in 2022, owing to the rising due to the Rising demand for adult healthcare services, including parenteral nutrition therapy, and increasing focus on specific nutritional needs and treatments of adult patients are fueling the adult segment in the TPN bags market.

On the basis of application, the total parenteral nutrition (TPN) bags market is segmented into oncology, gastroenterology, neurology, diabetes, and others. The Oncology segment holds 34.4% market value share in 2022, owing to the rising due to the Advances in healthcare technology and the development of innovative formulations and delivery methods boost the adoption of TPN bags for the treatment of the Oncology, thereby driving the segment.

Based on material, the total parenteral nutrition (TPN) bags are segmented into EVA (Ethylene Vinyl Acetate), PP (polypropylene) and others. The EVA (Ethylene Vinyl Acetate) segment holds 85.5% market value share in 2022, owing to the high demand for environmentally-friendly materials such as EVA, which are used in TPN bags. This trend towards eco-friendly materials is promoting the development and adoption of EVA infusion bags in the healthcare sector.

Based on end-user, the total parenteral nutrition (TPN) bags is segmented into home, hospital & clinic, and others. The hospital & clinic segment holds 67.2% market value share in 2022, owing growing demand for TPN bags in hospitals and clinics for patients requiring parenteral nutrition support. Healthcare facilities rely on TPN bags to provide essential nutrients to patients who cannot consume food orally.

On the basis on distribution channel, the total parenteral nutrition (TPN) bags is segmented into offline, and online. The offline segment holds 81.9% market value share in 2022, as in urgent situations, hospitals require immediate TPN bag supplies. Offline channels offer the advantage of faster response times and direct communication compared to online ordering.

The outbreak of Coronavirus disease in 2019 (COVID-19) restrained the global economy, created global interdependence, and challenged the governments of various nations. The pandemic has also led to increased investment in research and development for COVID-19 treatments and vaccines. This may have a secondary impact on the TPN bags market, as the development of effective treatments and vaccines could potentially reduce the number of patients requiring TPN therapy in the long run.

Moreover, the COVID-19 pandemic has had a profound impact on the Global Total Parenteral Nutrition (TPN) Bags Market, with increased demand, supply chain disruptions, price fluctuations, and shifts in healthcare priorities being some of the major effects. As the pandemic continues to evolve, it is essential for the market to adapt and respond to these changes to ensure the availability and accessibility of TPN bags for patients in need.

According to a study published in the Journal of Parenteral and Enteral Nutrition, the number of COVID-19 patients requiring critical care ranged from 15% to 25% of the total confirmed cases. This indicates a considerable increase in the demand for TPN bags to support these critically ill patients.

The Future of the Total Parenteral Nutrition (TPN) Bags Market:

The Total Parenteral Nutrition (TPN) bags market is expected to experience significant growth in the coming years, driven by several factors. One of the main drivers of this growth is the increasing demand for TPN bags, which is expected to rise due to the growing prevalence of chronic diseases, such as cancer, Crohn's disease, and ulcerative colitis, which require long-term parenteral nutrition support. This demand is expected to be further fueled by the increasing use of TPN bags in hospitals and clinics.

Innovations in TPN technology are also expected to play a key role in shaping the future of the market. Advances in technology, such as the development of smaller, more portable bags and more efficient infusion systems, will improve patient outcomes and reduce healthcare costs. New products, such as ready-to-use bags and pre-mixed solutions, will also simplify the administration process and reduce the risk of medication errors.

As healthcare providers continue to face pressure to reduce costs while maintaining quality care, there will be a growing emphasis on cost-effective solutions. This includes the use of generic or biosimilar medications, as well as the development of more affordable TPN bags. The increasing popularity of home parenteral nutrition (HPN) therapy will also drive demand for TPN bags that can be used in home settings, requiring manufacturers to develop products that are easier to use and more convenient for patients.

Market Key Developments

In July 2023, Baxter International Inc. announced the launch of PERCLOT Absorbable Hemostatic Powder in the US. PERCLOT is a passive, absorbable hemostatic powder that is ready to use and designed for patients with intact coagulation to address mild bleeding.

In June 2023, Baxter International Inc. announced the US launch of Hillrom Progressa+ bed for the ICU. Progressa+ offers technology and features that help make it easy for nurses to care for patients, while supporting patient recovery.

In March 2022, B. Braun SE acquired Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates. The fully automated ECOMix mixing system developed by Intermedt enables dialysis centers to prepare the acid concentrates required for hemodialysis in a simple, flexible, and environmentally friendly manner.

In November 2021, B. Braun SE announced the partnership with REVA Medical for the distribution of Fantom Encore - a bioresorbable scaffold for coronary interventions, manufactured with REVA's patented material Tyrocore.

The players in the Global Total Parenteral Nutrition (TPN) Bags Market include Baxter International Inc.; B. Braun SE; Valmed S.r.l.; Generic Specialties, Inc; INFRA S.r.l.; Paolo Gobbi Frattini S.r.l.; Kapsam Health Products; Huali Technology Co., Ltd; Vitaimed Instrument Co., Ltd.; Boen Healthcare Co., Ltd. And Others.

Target Audience:

• Supply-side: Manufacturer, Suppliers and End-users.

• Demand Side: Hospitals & Clinics, Ambulatory Surgical Centers, Others.